OTC records inspection legislation would have little impact on agency policy -- FDAers.
This article was originally published in The Tan Sheet
Executive Summary
OTC DRUG RECORDS INSPECTION INCREASED FREQUENCY UNLIKELY if authorized under pending FDA reform legislation, FDA Central Region Assistant Director Joseph Phillips told the Nonprescription Drug Manufacturers Association Manufacturing Controls Seminar in Philadelphia Oct. 9-10. "I wouldn't expect to see us storming out there to demand what we haven't done in the past," Phillips commented.